Linda Nelson, Managing Director
Linda Nelson has been the Managing Director of MELISA since 2005. After witnessing how MELISA testing has helped patients recover from chronic illnesses, she has made it her aim to raise awareness of how metals can induce serious health problems in sensitive individuals. She does this by: encouraging and enabling research, working with licensed MELISA laboratories to develop new applications for testing and by organising international conferences.
Olaf Beckord, Dipl. Chem. Ing (GER)
Olaf Beckord trained as an Analytical Chemist and has headed up several German laboratories. For 12 years, Olaf was the Technical Director of InVitaLab, Neuss, working with MELISA testing. Together with Prof Vera Stejskal, he has developed testing for new substances using the MELISA protocol.
Olaf continues to provide medical and scientific support as well as participating in conferences and training new laboratories to perform MELISA testing under license.
Dr Birgitta Brunes, MD
Dr Brunes is a general practitioner who specializes in the treatment of multiple sclerosis. She was herself diagnosed with MS, but is now cured as showed by MRI. She has published a book on her experience: “From Multiple Sclerosis to Better Health”.
Mrs Rebecca Dutton
Mrs Dutton’s personal experience with mercury-induced ill-health encouraged her to collate scientific evidence on the effect of mercury on health. At the same time, she set up a patient support group to offer advice and guidance to others with similar symptoms. She is particularly interested in the role of mercury in the development of scoliosis.
Dr Jose Mendonça Caridad, MD, DDS
Dr Mendonça Caridad is a doctor, dentist and oral and maxillofacial surgeon. Previously a Clinical and Research Fellow in Oral and Maxillofacial Surgery at the UCLA School of Dentistry, he is now working at the Polusa hospital in Lugo, Spain. He uses autologous stem cells for reconstruction and rehabilitation of the oral cavity. He is the co-author of the first clinical paper on stem cell therapies in advanced disease in the head and neck region and of one of the first clinical papers on stem cells (published in Journal of Plastic and Reconstructive Surgery in 2010). He also works as a volunteering surgeon in Africa and helps rebuild the faces of children with deformities.
Dr Jenny Stejskal, MD
Dr Stejskal is one of the first ever specialists in Anti-aging medicine in Scandinavia. In addition to research for the MELISA Medica Foundation, she has conducted research on human growth hormone at the Karolinska Institute in Stockholm. She is a specialist in general medicine in Stockholm. She is the author of several papers on metal allergy.
Prof. Vera Stejskal (1944-2017), Associate Professor of Immunology
Prof. Stejskal passed away in 2017. She was the inventor of the MELISA test, formerly head of Immunotoxicology at Astra Pharmaceuticals (now known as AstraZeneca), where she played a key role developing Losec, Astra’s multi-billion-dollar stomach ulcer drug. She left Astra in 1996 to concentrate full-time on MELISA and became Associate Professor of Immunology at the University of Stockholm. She has written numerous articles on metal allergy and gave frequent lectures.